Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03696199 · ClinicalTrials.gov registry record · Phase 4

Randomized Controlled Trial for Ankle Fracture Pain Control

A Phase 4 study of Ankle Fractures, sponsored by Lahey Clinic.

Recruiting
Registry status
Phase 4
Development phase
70
Enrollment target
1
Study location

NCT03696199 is a Phase 4 study of Ankle Fractures that is actively recruiting participants, run by Lahey Clinic. The registered enrollment target is 70 participants, below the 248-participant average among 12 other Ankle Fractures trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03696199, a Phase 4 study of Ankle Fractures, is actively recruiting participants, sponsored by Lahey Clinic.

RECRUITING
Registry status
Phase 4
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This project is a multicenter, three armed, prospective randomized control trial studying the effectiveness of a long-acting local anesthetic "cocktail" in patients undergoing operative fixation of ankle fractures.

Conditions Studied

Interventions

  • DRUG Regional Anesthesia
  • DRUG Long-Acting Local Anesthesia

Study Locations (1)

Massachusetts

  • Lahey Hospital & Medical Center - Burlington

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2020-09-01
Est. Completion 2027-09-01
Phase Phase 4

Sponsor

Lahey Clinic

43 total trials

What the Registry Record Tells You About NCT03696199

The ClinicalTrials.gov registry entry for NCT03696199 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 248-participant average among 12 other Ankle Fractures trials with a reported enrollment target (72% lower). The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ankle Fractures appearing as the primary indexed condition, and to 2 interventions - of which Regional Anesthesia is the first listed.

NCT03696199 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03696199 about?

NCT03696199 is a clinical study titled "Randomized Controlled Trial for Ankle Fracture Pain Control". This project is a multicenter, three armed, prospective randomized control trial studying the effectiveness of a long-acting local anesthetic "cocktail" in patients undergoing operative fixation of ankle fractures.

What is the current status of trial NCT03696199?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2020-09-01. Estimated completion is 2027-09-01.

What conditions does trial NCT03696199 study?

This clinical trial studies the following conditions: Ankle Fractures.

What interventions are being tested in trial NCT03696199?

The interventions under investigation include: Regional Anesthesia (DRUG), Long-Acting Local Anesthesia (DRUG).

Who is sponsoring clinical trial NCT03696199?

This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03696199 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ankle Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.